Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1003-1008

  Malm, G ^a   Ringden O ^a   Winiarski, J ^a   Grondahl E ^a   Uvebrant, P ^b   Eriksson, U ^c   Hakansson H ^d   Skjeldal, O ^e   Mansson J E ^f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ÖSTERSUND HOSPITAL   (Sweden)

^d Kalmar Hospital   (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone marrow transplantation; Metachromatic leukodystrophy

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHILD; DEMYELINATION; DISEASE COURSE; FEMALE; FOLLOW UP; GAIT DISORDER; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL CAPACITY; METACHROMATIC LEUKODYSTROPHY; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPEECH; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMANS; LEUKODYSTROPHY, METACHROMATIC; MALE;

EID: 0030036466     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kolodny EH, Fluharty AL. Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CS, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. McGrawHill: New York, 1995, pp 2693-2739.
2. Hagberg B. Clinical symptoms, signs and tests in metachromatic leukodystrophy. In: Folch-Pi J, Bauer H (eds). Brain Lipids and Lipoproteins and Leukodystrophies. Elsevier: Amsterdam, 1963, pp 134-146.
3. MacFaul R, Cavanagh N, Lake BD et al. Metachromatic leukodystrophy: a review of 38 cases. Arch Dis Childhood 1982; 57: 168-175.
4. Polten A, Flutharty AL, Flutharty CB et al. Molecular basis of different forms of metachromatic leukodystrophy. New Engl J Med 1991; 324: 18-22.
5. Hobbs JR. Bone marrow transplantation for inborn errors. Lancet 1981; ii: 735-739.
6. Groth CG, Ringdén O. Transplantation in relation to the treatment of inherited disease. Transplantation 1984; 38: 319-327.
7. Ringdén O, Groth CG, Aschan J et al. Bone marrow transplantation for metabolic disorders at Huddinge Hospital. Transplant Proc 1990; 22: 198-202.
8. Krivit W, Shapiro EG. Bone marrow transplantation for storage diseases. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publication: Oxford, 1994, pp 883-893.
9. Krivit W, Shapiro E, Lockman L et al. Recommendations for treatment of metachromatic leukodystrophy by bone marrow transplantation based on a review of seven patients who have been engrafted for at least 1 year. In: Hobbs JR, Riches PG (eds). Correction of Certain Genetic Diseases by Transplantation. COGENT II, Westminster Medical School Press: London, 1991, pp 57-72.
10. Krivit W, Lockman LA, Watkins PA et al. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inher Metab Dis 1995; 18: 398-412.
11. Walkley SU, Thrall MA, Dobrenisk K et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994; 91: 2970-2974.
12. Hoogerbrugge PM, Brouwer OF, Bordigoni P et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet 1995; 345: 1398-1402.
13. Walkley SU, Dobrenis K. Bone marrow transplantation for lysosomal diseases. Lancet 1995; 345: 1382-1383.
14. Pridjian G, Humbert J, Willis J et al. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J Pediatr 1994; 125: 755-758.
15. Bayever E, Ladish S, Philippant M et al. Bone marrow transplantation of metachromatic leukodystrophy. Lancet 1985; 2: 471-473.
16. Krivit W, Lipton ME, Lockman LA. Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am J Med Sci 1987; 294: 80-85.
17. Shapiro EG, Lipton ME. White matter dysfunction and its neurophysicological correlates: a longitudinal study of a case of metachromatic leucodystrophy treated with bone marrow transplantation. J Clin Exp Neuropsychol 1992; 14: 610-624.
18. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
19. Ringdén O, Bäckman L, Lönnqvist B et al. A randomized trial comparing the use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies. Bone Marrow Transplant 1986; 1: 41-51.
20. Ringdén O, Bolme P, Lönnqvist B et al. Bone marrow transplantation in children. Clin Transplant 1989; 3: 12-18.
21. Svennerholm L, Håkansson G, Månsson J-E, Vanier M-T. The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta 1979; 92: 53-64.
22. Davidsson P, Fredman P, Månsson J-E, Svennerholm L. Determination of gangliosides and sulfatide in human cerebrospinal fluid with microimmunoaffinity technique. Clin Chim Acta 1991; 197: 105-116.
23. Smith PK, Krohn RJ, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
24. Krivit W, Shapiro E, Lipton M et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. New Engl J Med 1990; 322: 28-32.